Carregant...
Nivolumab-induced fulminant diabetic ketoacidosis followed by thyroiditis
Five days following the 3rd cycle of nivolumab, a monoclonal antibody, which acts as immune checkpoint inhibitor against the programmed cell death protein-1, for metastatic lung adenocarcinoma, a 56-year-old woman presented at the hospital critically ill. On admission, she had severe diabetic ketoac...
Guardat en:
| Publicat a: | Endocrinol Diabetes Metab Case Rep |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Bioscientifica Ltd
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5863245/ https://ncbi.nlm.nih.gov/pubmed/29576870 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EDM-18-0111 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|